Delivery Order SPE2DB22D3009-SPE2DB24FAV74
Award Date
5/2/24
Potential Completion Date
5/3/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $3,168.29 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Budesonide-Formoterol 160-4.5 10.2GM medication. This order is part of a larger $999,999,999 indefinite delivery contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support...
The U.S. Defense Logistics Agency (DLA) awarded a $3,619.08 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product Budesonide-Formoterol 160-4.5 10.2GM. This order is part of Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this...
The U.S. Defense Logistics Agency (DLA) awarded a $5,607.17 firm-fixed-price delivery order to Amerisourcebergen Drug Corp for the supply of 4,565,321,019 units of Budesonide-Formoterol 80-4.5 10.2GM, a critical pharmaceutical product. This delivery order is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $1,321.67 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,204,806 units of the medication Budesonide-Formoterol 80-4.5 10.2GM. The contract has an ultimate completion date of May 12, 2025 and is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,959.18 firm-fixed-price delivery order is for the supply of 4567405225 units of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract has an ultimate completion date of February 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,960.20 delivery order contract is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a respiratory medication, with a completion date of November 27, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of the pharmaceutical product Budesonide-Formoterol 160-4.5 10.2GM to the Defense Logistics Agency (DLA). The $2,843.28 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a range of...
This federal contract award, valued at $2,087.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, which has no set-aside designation, is a delivery order for the supply of 4,558,638,420 units of the medication Budesonide-Formoterol 160-4.5 10.2GM. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,278.81 firm fixed-price delivery order is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a respiratory medication. The contract has an ultimate completion date of October 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,561.75 Firm Fixed Price Delivery Order is for the supply of the medication Budesonide-Formoterol 80-4.5 10.2GM. The contract has an ultimate completion date of November 14, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...